Professor Esam Z. Dajani PhD, FACG
,
IDDC Corporation
1549 RFD
Long Grove, IL
60047-9532
Phone: (847) 634-9586
Fax: (847) 634-3349
Profile:
Professor Dajani has broad expertise in clinical pharmacology, toxicology, drug development, regulatory affairs, patents and Contract Research Organizations (CROs). He has over 30 years experience in pharmaceutical research and development. He was most instrumental in the discovery and development of Cyotec, a worldwide anti-ulcer drug. He is the president and founder of IDDC Corporation, a CRO which provides consulting services for pharmaceutical companies, law firms and governmental agencies. He also holds Adjunct Professor of Medicine appointment at Loyola University Chicago and previously held Adjunct Professor of Pharmacology appointment at Chicago Medical School. He provides investigations, research, record analysis, consultation, merit statement and testimony.
Years as Expert: 15 Years
Alternate email address: EsamD@aol.com
Education/Licenses:
PhD (Pharmacology & Toxicology), MS (Pharmacology & Medicinal Chemistry), BS (Pharmacy), Licensed Pharmacist.
Primary Area of Expertise: Pharmacology
Law.com Home
